CAROL MARKS: Open Payments
NPI 1437133717 · BOONE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 21 payments from 9 companies in 2025. Trend: 2023 $436 · 2024 $763 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $282 |
| ABBVIE INC. | 4 | $209 |
| Amgen Inc. | 1 | $97 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $49 |
| Janssen Biotech, Inc. | 2 | $42 |
| Lilly USA, LLC | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Organon LLC | 1 | $15 |
Products named: Bimzelx, SKYRIZI, OTEZLA, TREMFYA, ILUMYA, RINVOQ, EBGLYSS, NEMLUVIO.
Industry payments across NC — which companies pay providers there.
